1. Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer. Issue 6 (25th June 2019) Authors: Liu, Yi‐Nan; Tsai, Meng‐Feng; Wu, Shang‐Gin; Chang, Tzu‐Hua; Tsai, Tzu‐Hsiu; Gow, Chien‐Hung; Chang, Yih‐Leong; Shih, Jin‐Yuan Journal: International journal of cancer Issue: Volume 145:Issue 6(2019) Page Start: 1609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Heparin co‐factor II enhances cell motility and promotes metastasis in non‐small cell lung cancer. Issue 1 (1st October 2014) Authors: Liao, Wei‐Yu; Ho, Chao‐Chi; Hou, Hsin‐Han; Hsu, Tsi‐Hsuan; Tsai, Meng‐Feng; Chen, Kuan‐Yu; Chen, Hsuan‐Yu; Lee, Yung‐Chie; Yu, Chong‐Jen; Lee, Chau‐Hwang; Yang, Pan‐Chyr Journal: Journal of pathology Issue: Volume 235:Issue 1(2015) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗